


PAION Revenue
Pharmaceutical Manufacturing • Aachen, North Rhine-Westphalia, Germany • 11-20 Employees
PAION revenue & valuation
| Annual revenue | $15,100,000 |
| Revenue per employee | $885,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $48,100,000 |
| Total funding | $6,100,000 |
Key Contact at PAION
Eliz Kelebek
Director Of Regulatory Affairs
Company overview
| Headquarters | Heussstraße 25, Aachen, Nordrhein-Westfalen 52078, DE |
| Phone number | +4924144530 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 2000 |
| Employees | 11-20 |
| Socials |
PAION Email Formats
PAION uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@paion.de), used 55.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@paion.de | 77.8% |
{first initial}.{last name} | j.doe@paion.com | 22.2% |
About PAION
PAION AG is a publicly listed specialty pharmaceutical company with innovative drugs to be used in hospital-based sedation, anesthesia and critical care services. PAION’s lead compound is remimazolam, an intravenous, ultra-short-acting and controllable benzodiazepine sedative/anesthetic. PAION is rolling out remimazolam (Byfavo®) in selected European markets. Remimazolam is partnered in multiple territories outside of Europe. Remimazolam is approved in the U.S., the EU/EEA/UK, China and South Korea for procedural sedation and in Japan and South Korea for general anesthesia. In addition, PAION markets two intensive care products in selected European countries: Angiotensin II (GIAPREZA®), a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock, and eravacycline (XERAVA®), a novel fluorocycline type of antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. PAION’s mission is to be a leading specialty pharmaceutical company in the fields of anesthesia and critical care by bringing novel products to market to benefit patients, doctors and other stakeholders in healthcare. PAION is headquartered in Aachen (Germany). PAION AG is listed on the Frankfurt Stock Exchange (Prime Standard Regulated Market, ticker symbol PA8, ISIN DE000A0B65S3).
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
PAION has 4 employees across 4 departments.
Departments
Number of employees
PAION Tech Stack
Discover the technologies and tools that power PAION's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Reverse proxies
JavaScript libraries
Programming languages
JavaScript libraries
Webmail
CMS
UI frameworks
Miscellaneous
Frequently asked questions
4.8
40,000 users



